We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
3976
CALL
T. Rowe Price
TROW
$23.9B
$1.66M ﹤0.01%
21,400
+6,400
+43% +$517K
KSU
3977
CALL
DELISTED
Kansas City Southern
KSU
$1.66M ﹤0.01%
18,200
-12,300
-40% -$1.21M
RFP
3978
DELISTED
Resolute Forest Products Inc.
RFP
$1.66M ﹤0.01%
147,514
+95,025
+181% +$1.32M
FPO
3979
DELISTED
First Potomac Realty Trust
FPO
$1.66M ﹤0.01%
160,858
+37,959
+31% +$409K
MYGN icon
3980
CALL
Myriad Genetics
MYGN
$270M
$1.66M ﹤0.01%
48,700
-34,400
-41% -$1.17M
PCH
3981
DELISTED
PotlatchDeltic
PCH
$1.65M ﹤0.01%
46,820
-28,319
-38% -$1.04M
ITCI
3982
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.65M ﹤0.01%
51,708
+37,104
+254% +$941K
JBL icon
3983
CALL
Jabil
JBL
$33B
$1.65M ﹤0.01%
77,500
+32,900
+74% +$776K
CHH icon
3984
Choice Hotels
CHH
$5.07B
$1.64M ﹤0.01%
30,294
-23,239
-43% -$1.36M
ALIM
3985
DELISTED
Alimera Sciences
ALIM
$1.64M ﹤0.01%
23,746
+20,829
+714% +$1.44M
NAT icon
3986
PUT
Nordic American Tanker
NAT
$1.38B
$1.64M ﹤0.01%
116,021
+61,186
+112% +$784K
KPTI icon
3987
CALL
Karyopharm Therapeutics
KPTI
$43.5M
$1.63M ﹤0.01%
4,000
+667
+20% +$288K
KPTI icon
3988
PUT
Karyopharm Therapeutics
KPTI
$43.5M
$1.63M ﹤0.01%
4,000
+667
+20% +$288K
LL
3989
DELISTED
LL Flooring Holdings, Inc.
LL
$1.63M ﹤0.01%
78,862
-114,148
-59% -$3M
GZT
3990
DELISTED
Gazit-globe Ltd
GZT
$1.63M ﹤0.01%
137,548
+97,498
+243% +$1.24M
AGQ icon
3991
PUT
ProShares Ultra Silver
AGQ
$1.13B
$1.63M ﹤0.01%
44,475
+9,975
+29% +$401K
HUN icon
3992
PUT
Huntsman Corp
HUN
$1.71B
$1.63M ﹤0.01%
73,700
-38,400
-34% -$869K
RESI
3993
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$1.63M ﹤0.01%
96,541
-41,870
-30% -$788K
CODI icon
3994
Compass Diversified
CODI
$758M
$1.62M ﹤0.01%
99,007
-2,349
-2% -$39.4K
CHCO icon
3995
City Holding Co
CHCO
$2.05B
$1.62M ﹤0.01%
32,947
-14,168
-30% -$667K
NCI
3996
DELISTED
Navigant Consulting, Inc.
NCI
$1.62M ﹤0.01%
108,944
-29,251
-21% -$416K
RDN icon
3997
CALL
Radian Group
RDN
$5.18B
$1.62M ﹤0.01%
86,300
-19,500
-18% -$350K
EGO icon
3998
PUT
Eldorado Gold
EGO
$7.87B
$1.62M ﹤0.01%
78,160
+8,840
+13% +$208K
PSCE icon
3999
Invesco S&P SmallCap Energy ETF
PSCE
$98.6M
$1.62M ﹤0.01%
12,249
ABB
4000
PUT
DELISTED
ABB Ltd
ABB
$1.62M ﹤0.01%
77,500
+52,100
+205% +$1.14M

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.